Gesynta Pharma was founded on the basis of:
access to potent and selective mPGES-1 inhibitors for pharmacological research and clinical development
proprietary knowledge of novel aspects of biological/medical effects caused by mPGES-1 inhibition leading to new opportunities in novel indications a team with extensive experience. Gesynta Pharma has been supported by Karolinska Institutet Innovation AB, Novo Nordisk Foundation,...
Gesynta Pharma was founded on the basis of:
access to potent and selective mPGES-1 inhibitors for pharmacological research and clinical development
proprietary knowledge of novel aspects of biological/medical effects caused by mPGES-1 inhibition leading to new opportunities in novel indications a team with extensive experience. Gesynta Pharma has been supported by Karolinska Institutet Innovation AB, Novo Nordisk Foundation, Swelife and VINNOVA - Swedish Governmental Agency for Innovation
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.